Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 76 AL 90

Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease

Flanagan ME, Marshall DA, Shofer JB, Montine KS, Nelson PT, Montine TJ, Keene CD.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):39-43. doi: 10.1093/jnen/nlw104.

Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach

Seifan A, Ganzer CA, Vermeylen F, Parry S, Zhu J, Lyons A, Isaacson R, Kim S.

J Public Health (Oxf). 2017 Dec 1;39(4):863-873. doi: 10.1093/pubmed/fdw145.

Heterozygous Deletion of Chorein Exons 70-73 and GNA14 Exons 3-7 in a Brazilian Patient Presenting With Probable Tau-Negative Early-Onset Alzheimer Disease

Lazarczyk MJ, Haller S, Savioz A, Gimelli S, Bena F, Giannakopoulos P.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):82-85. doi: 10.1097/WAD.0000000000000185.

Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends

Bachurin SO, Bovina EV, Ustyugov AA.

Med Res Rev. 2017 Sep;37(5):1186-1225. doi: 10.1002/med.21434. Epub 2017 Jan 13.

Chronoinflammaging in Alzheimer; A systematic review on the roles of toll like receptor 2

Ravari A, Mirzaei T, Kennedy D, Kazemi Arababadi M.

Life Sci. 2017 Feb 15;171:16-20. doi: 10.1016/j.lfs.2017.01.003. Epub 2017 Jan 11.

Synaptic Plasticity, Dementia and Alzheimer Disease

Skaper SD, Facci L, Zusso M, Giusti P.

CNS Neurol Disord Drug Targets. 2017;16(3):220-233. doi: 10.2174/1871527316666170113120853.

Case-control association mapping by proxy using family history of disease

Liu JZ, Erlich Y, Pickrell JK.

Nat Genet. 2017 Mar;49(3):325-331. doi: 10.1038/ng.3766. Epub 2017 Jan 16.

The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind

Ricciarelli R, Fedele E.

Curr Neuropharmacol. 2017;15(6):926-935. doi: 10.2174/1570159X15666170116143743.

Update on Alzheimer's Disease Therapy and Prevention Strategies

Graham WV, Bonito-Oliva A, Sakmar TP.

Annu Rev Med. 2017 Jan 14;68:413-430. doi: 10.1146/annurev-med-042915-103753.

Multicellular hypothesis for the pathogenesis of Alzheimer's disease

Goetzl EJ, Miller BL.

FASEB J. 2017 May;31(5):1792-1795. doi: 10.1096/fj.201601221R. Epub 2017 Jan 18.

Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities

Bechten A, Wattjes MP, Purcell DD, Aliaga ES, Daams M, Brashear HR, Arrighi HM, Barkhof F.

J Neuroimaging. 2017 May;27(3):318-325. doi: 10.1111/jon.12422. Epub 2017 Jan 19.

Next generation tau models in Alzheimer's disease research - virus based gene delivery systems

Cubinková V, Valachová B, Brezováková V, Szabó R, Zimová I, Kostecká Z, Jadhav S.

Acta Virol. 2017;61(1):13-21. doi: 10.4149/av_2017_01_13.

A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains

Haddick PC, Larson JL, Rathore N, Bhangale TR, Phung QT, Srinivasan K, Hansen DV, Lill JR; Alzheimer’s Disease Genetic Consortium (ADGC), Alzheimer’s Disease Neuroimaging Initiative (ADNI); Pericak-Vance MA, Haines J, Farrer LA, Kauwe JS, Schellenberg GD, Cruchaga C, Goate AM, Behrens TW, Watts RJ, Graham RR, Kaminker JS, van der Brug M.

J Alzheimers Dis. 2017;56(3):1037-1054. doi: 10.3233/JAD-160524.

Astrocytic transporters in Alzheimer's disease

Ugbode C, Hu Y, Whalley B, Peers C, Rattray M, Dallas ML.

Biochem J. 2017 Feb 1;474(3):333-355. doi: 10.1042/BCJ20160505.

Management of Alzheimer's disease-An insight of the enzymatic and other novel potential targets

Islam BU, Tabrez S.

Int J Biol Macromol. 2017 Apr;97:700-709. doi: 10.1016/j.ijbiomac.2017.01.076. Epub 2017 Jan 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias